Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Saved in:
| Title: | Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study. |
|---|---|
| Authors: | Azuly, Hovav1 (AUTHOR), Shafat, Tali1,2,3 (AUTHOR), Grupel, Daniel4,5 (AUTHOR), Porges, Tzvika5,6 (AUTHOR), Abuhasira, Ran2 (AUTHOR), Belkin, Ana7,8 (AUTHOR), Deri, Ofir9 (AUTHOR), Oster, Yonatan4,5 (AUTHOR), Zahran, Shadi4,5 (AUTHOR), Horwitz, Ehud4,5 (AUTHOR), Horowitz, Netanel A.10 (AUTHOR), Khatib, Hazim10 (AUTHOR), Batista, Marjorie Vieira11 (AUTHOR), Cortez, Anita Cassoli12 (AUTHOR), Brosh-Nissimov, Tal13,14 (AUTHOR), Segman, Yafit14,15 (AUTHOR), Ishay, Linor16,17 (AUTHOR), Cohen, Regev16,17 (AUTHOR), Atamna, Alaa18 (AUTHOR), Spallone, Amy3 (AUTHOR) |
| Source: | Infectious Diseases & Therapy. Jan2025, Vol. 14 Issue 1, p167-180. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938229 |
|---|---|
| DOI: | 10.1007/s40121-024-01089-9 |
